Genmab
GMAB
97 hedge funds and large institutions have $511M invested in Genmab in 2019 Q3 according to their latest regulatory filings, with 97 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.85% more ownership
Funds ownership: 0% → 3.85% (+3.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$75.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$62M |
| 3 |
Lazard Asset Management
New York
|
+$33.4M |
| 4 |
BlackRock
New York
|
+$29.9M |
| 5 |
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$29.5M |
Top Sellers
GMAB Hedge Fund Activity: Q3 2019 in Review
97 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2019, worth a combined $511M.
Buyers outnumbered sellers: 97 funds opened new GMAB positions and 0 closed out — a net gain of 97 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Artisan Partners, opening a new position worth an estimated $75.8M.
- 97 institutional investors held Genmab (GMAB) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $511M of Genmab stock for Q3 2019.
- 97 funds opened new Genmab positions in Q3 2019 and 0 closed out, a net change of +97 holders.
- The largest Genmab buyer in Q3 2019 was Artisan Partners, an estimated $75.8M added.
Based on aggregated 13F filings for Q3 2019.